# OnCo record isabelle-ray-coquard (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/isabelle-ray-coquard/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "isabelle-ray-coquard" ;
  schema:name "Isabelle Ray-Coquard"@en ;
  schema:description "Led PAOLA-1, which showed olaparib plus bevacizumab helps women with HRD-positive ovarian cancer beyond BRCA carriers."@en ;
  schema:url <https://onco.cc/people/isabelle-ray-coquard/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Ray-Coquard%20I%5BAuthor%5D%20ovarian%20PAOLA> ;
  onco:tag "ovarian", "parp", "hrd" ;
  schema:jobTitle "Professor of Medical Oncology, Centre Léon Bérard and Université Claude Bernard Lyon 1; President, GINECO" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/hrd-testing/>, <https://onco.cc/technologies/antiangiogenic/> ;
  onco:targets <https://onco.cc/targets/parp/>, <https://onco.cc/targets/brca/>, <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/> ;
  onco:companies <https://onco.cc/companies/arcagy-gineco/> ;
  onco:institutions <https://onco.cc/institutions/centre-leon-berard/> ;
  onco:trials <https://onco.cc/trials/paola-1/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-paola-1-nejm-2019/> ;
  schema:affiliation <https://onco.cc/institutions/centre-leon-berard/> .